|
Ref. no.
|
Sex
|
Deaths (n)
|
Hazard ratio
|
95% CI
|
|---|
|
Cardiovascular disease
|
|
[19]
|
Men
|
602a
|
0.93
|
0.86–1.02
|
| |
Women
|
1018a
|
0.89
|
0.84–0.95*
|
|
Coronary disease
| | |
|
[17]
|
Men
|
649
|
0.99
|
0.91–1.06
|
|
Heart disease
| | |
|
[20]
|
Men
|
1525b
|
0.96
|
0.92–1.00#
|
| |
Women
|
920b
|
0.98
|
0.91–1.04
|
|
Ischemic heart diseases
| | |
|
[16]
|
Women
|
408
|
0.93
|
0.85–1.03
|
|
[19]
|
Men
|
63
|
0.97
|
0.84–1.13
|
| |
Women
|
90
|
0.92
|
0.80–1.06
|
|
Myocardial infarction
| | |
|
[20]
|
Men
|
579
|
0.99
|
0.92–1.06
|
| |
Women
|
291
|
0.91
|
0.81–1.02
|
|
Stroke
| | |
|
[16]
|
Women
|
1521
|
0.84
|
0.80–0.88*
|
|
[17]
|
Men
|
1263
|
0.93
|
0.88–0.98*
|
|
[18]
|
Men
|
158c
|
0.92
|
0.79–1.08
|
| |
Women
|
168c
|
0.77
|
0.64–0.91*
|
|
[19]
|
Men
|
104
|
0.88
|
0.78–1.00#
|
| |
Women
|
208
|
0.89
|
0.82–0.97*
|
|
Cerebrovascular disease
| | |
|
[20]
|
Men
|
1133c
|
0.95
|
0.90–0.99*
|
| |
Women
|
758c
|
0.92
|
0.86–0.99*
|
|
Hemorrhagic stroke
| | |
|
[16]
|
Women
|
502
|
0.83
|
0.76–0.91*
|
|
[17]
|
Men
|
636
|
0.88
|
0.82–0.96*
|
|
[18]
|
Men
|
37
|
0.85
|
0.62–1.16
|
| |
Women
|
26
|
1.05
|
0.70–1.55
|
|
[20]
|
Men
|
512
|
0.89
|
0.82–0.96*
|
| |
Women
|
410
|
0.87
|
0.76–0.99*
|
|
Ischemic stroke
| | |
|
[16]
|
Women
|
323
|
0.82
|
0.73–0.91*
|
|
[17]
|
Men
|
262
|
0.98
|
0.87–1.10
|
|
[18]
|
Men
|
97
|
0.92
|
0.75–1.13
|
| |
Women
|
69
|
0.66
|
0.51–0.84*
|
|
[20]
|
Men
|
290
|
1.01
|
0.92–1.12
|
| |
Women
|
185
|
1.02
|
0.89–1.17
|
- CI confidence interval, NA not applicable
- P-value: * <0.05 (significance), # approximately 0.05 (marginal significance)
- aIncludes deaths from ischemic heart disease, stroke, and other circulatory diseases
- bIncludes deaths from myocardial infarction
- cIncludes deaths from ischemic stroke, hemorrhagic stroke, and strokes of undetermined type
